Agile and Fast: Enabling Rapid Market Launch of Innovative Drugs from Preclinical to Commercialization in 18 Months

In response to the surge in demand within the healthcare market, a client needed to expedite the launch of an innovative drug product while facing
challenges such as process instability, mass production demand, and tight delivery schedules. As a CDMO company serving the global innovative drug industry, Porton has extensive experience in providing R&D and manufacturing services. Porton offers comprehensive, reliable, swift, compliant, and
all-inclusive services, spanning from R&D to delivery, ensuring clients’ commercial success.